Business Context and Reporting Period
This Form 8-K is filed by AmerisourceBergen Corporation (now Cencora, Inc.) on September 9, 2009. The report announces an upcoming presentation at the Robert W. Baird & Company, Inc. 2009 Healthcare Conference scheduled for September 10, 2009, in New York.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the current period. It references historical earnings per share (EPS) data for comparative purposes:
- Fiscal Year 2008 EPS: $1.44 (split-adjusted).
- Fiscal Year 2009 Guidance Range: $1.59 to $1.65 (diluted EPS from continuing operations).
Material Changes
The filing indicates an expected increase in diluted earnings per share for fiscal year 2009 of 10 percent to 15 percent compared to the split-adjusted results of fiscal year 2008.
Guidance, Outlook, and Management Commentary
Executive Vice President and Chief Financial Officer Michael D. DiCandilo intends to reaffirm the company's fiscal year 2009 guidance at the upcoming conference. Management continues to expect diluted earnings per share from continuing operations to be at the higher end of the projected range of $1.59 to $1.65. No specific risks, contingencies, or unusual items are detailed in this report.
Investor Verification Checklist
- Verify the actual earnings per share results for fiscal year 2009 against the reaffirmed guidance range of $1.59 to $1.65.
- Confirm the split-adjusted EPS of $1.44 for fiscal year 2008 to validate the reported 10-15% growth projection.
- Review subsequent filings for detailed revenue, margin, and liquidity data not included in this 8-K.